1-12 of 12
Yanni Hao
Close
Sort by
Journal Articles

Utilization of External Control Arm to Contextualize Clinical Efficacy of Tisagenlecleucel Treated Among Patients with Relapsed/Refractory Follicular Lymphoma from the Single-Arm Elara Trial

Yanni Hao, Wei-Chun Hsu, Craig S Parzynski, C Lobetti Bodoni, Lisa Hampson, Aisha Masood, Whitney Rhodes, Wen-Hsing Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 4506.
https://doi.org/10.1182/blood-2021-152685
Published: 2021
Journal Articles

Comparison of Clinical Outcomes Among Patients with Relapsed/Refractory Follicular Lymphoma Treated with Tisagenlecleucel in the Elara Trial Versus a Real-World External Control Arm of Patients Treated with Standard of Care

Yanni Hao, Wei-Chun Hsu, Craig S Parzynski, C Lobetti Bodoni, Evgeny Degtyarev, Lisa Hampson, Aisha Masood, Wen-Hsing Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2419.
https://doi.org/10.1182/blood-2021-147781
Published: 2021
Journal Articles

Estimation of Total Costs in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Receiving Tisagenlecleucel from a US Hospital's Perspective

Hongbo Yang, Yanni Hao, PhD, Xinglei Chai, PhD, Cynthia Z. Qi, MBA, Eric Q Wu
Journal: Blood
Blood (2019) 134 (Supplement_1): 3419.
https://doi.org/10.1182/blood-2019-129070
Published: 2019
Journal Articles

Estimation of Total Costs in Pediatric and Young Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Receiving Tisagenlecleucel from a US Hospital's Perspective

Hongbo Yang, Yanni Hao, PhD, Cynthia Z. Qi, MBA, Xinglei Chai, PhD, Eric Q Wu
Journal: Blood
Blood (2019) 134 (Supplement_1): 4723.
https://doi.org/10.1182/blood-2019-129215
Published: 2019
Journal Articles

Economic Burden of Neurologic Toxicities Associated with Treating Relapsed Refractory Diffuse Large B-Cell Lymphoma in the United States

Michael S Broder, MD MSHS, Qiufei Ma, PhD, Tingjian Yan, PhD, Eunice Chang, PhD, Lamis K. Eldjerou, MD, Yanni Hao, PhD, David Kuzan, MD, Jie Zhang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4719.
https://doi.org/10.1182/blood-2019-122587
Published: 2019
Journal Articles

Patient Profile and Treatment Patterns in a Commercially Insured Population with Follicular Lymphoma

Nathan H Fowler, MD, Yanni Hao, PhD, Stephen Lim, MD, Guifang Chen, PhD, Frank Li, PhD, Steve Arcona, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5880.
https://doi.org/10.1182/blood-2019-127237
Published: 2019
Journal Articles

CAR-T Therapy Displays Favorable Gains in Health Outcomes and Competitive Cost-Effectiveness When Compared with Past Innovative Cancer Treatments

James Baumgardner, PhD, Katie Everson, MS, Michelle Brauer, BS, Jie Zhang, PhD, Yanni Hao, PhD, Jamae Liu, PhD, Darius N Lakdawalla, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 322.
https://doi.org/10.1182/blood-2018-99-116763
Published: 2018
Journal Articles

The Economic Value of CTL019 Therapy for Pediatric Patients with Relapsed and Refractory Acute Lymphoblastic Leukemia in the United Kingdom

Julia Snider, PhD, Michelle Brauer, BS, Yanni Hao, PhD, Pinar Karaca-Mandic, PhD, Mahlet Gizaw Tebeka, MS, Jie Zhang, PhD, Katharine Batt, MD MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 1330.
https://doi.org/10.1182/blood.V130.Suppl_1.1330.1330
Published: 2017
Journal Articles

Cost-Effectiveness Analysis of CTL019 for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in the United States

Yanni Hao, PhD, Lamis K. Eldjerou, MD, Hongbo Yang, PhD, Cynthia Qi, MBA, Denise Globe, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 609.
https://doi.org/10.1182/blood.V130.Suppl_1.609.609
Published: 2017
Journal Articles

Clinical Outcomes Among Patients with Myelodysplastic Syndromes Treated with Iron Chelation Therapy: A Real World Medicare Database Study

Yanni Hao, PhD, Alex Z Fu, PhD, Austin Coe, Ying Qiu, PhD, Zhiyi Li, Becky Hanna, Jackson Tang, Brian M. Elliott, MD, Carole Paley, MD
Journal: Blood
Blood (2016) 128 (22): 2396.
https://doi.org/10.1182/blood.V128.22.2396.2396
Published: 2016
Journal Articles

Short-Term and Long-Term Economic Burden Following Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Adult Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Richard T. Maziarz, MD, Yanni Hao, PhD, Annie Guerin, MSc, Genevieve Gauthier, MSc, Marjolaine Gauthier-Loiselle, PhD, Simu K Thomas, PhD, Lamis K Eldjerou, MD
Journal: Blood
Blood (2016) 128 (22): 5933.
https://doi.org/10.1182/blood.V128.22.5933.5933
Published: 2016
Journal Articles

Treatment Patterns and Adherence Among Patients with Myelodysplastic Syndromes Receiving Deferasirox As Iron Chelation Therapy: A Real World Medicare Database Study

Alex Z Fu, PhD, Yanni Hao, PhD, Austin Coe, Ying Qiu, PhD, Zhiyi Li, Becky Hanna, Jackson Tang, Brian M. Elliott, MD, Carole Paley, MD
Journal: Blood
Blood (2016) 128 (22): 4759.
https://doi.org/10.1182/blood.V128.22.4759.4759
Published: 2016